| Copyright © 2009. National Academy of Sciences. All rights reserved. Terms of Use and Privacy Statement |
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page R1
Capitalizing on New Needs and New Opportunities: Government-Industry Partnerships in Biotechnology and Information Technologies
Capitalizing on New Needs and New Opportunities:
Government-Industry Partnerships in Biotechnology and Information Technologies
CHARLES W.WESSNER, EDITOR
Board on Science, Technology, and Economic Policy
Policy and Global Affairs
National Research Council
NATIONAL ACADEMY PRESS
Washington, D.C.
OCR for page R2
Capitalizing on New Needs and New Opportunities: Government-Industry Partnerships in Biotechnology and Information Technologies
NATIONAL ACADEMY PRESS
2101 Constitution Avenue, N.W. Washington, D.C. 20418
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.
Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the organizations or agencies that provided support for the project.
International Standard Book Number 0-309-08257-9
Limited copies are available from Board on Science, Technology, and Economic Policy, National Research Council, 1055 Thomas Jefferson Street, N.W., Suite 2014, Washington, D.C. 20007; 202–334–2200.
Additional copies of this report are available from
National Academy Press,
2101 Constitution Avenue, N.W., Lockbox 285, Washington, D.C. 20055; (800) 624–6242 or (202) 334–3313 (in the Washington metropolitan area); Internet, http://www.nap.edu
Printed in the United States of America
Copyright 2001 by the National Academy of Sciences. All rights reserved.
OCR for page R3
Capitalizing on New Needs and New Opportunities: Government-Industry Partnerships in Biotechnology and Information Technologies
THE NATIONAL ACADEMIES
National Academy of Sciences
National Academy of Engineering
Institute of Medicine
National Research Council
The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Bruce M.Alberts is president of the National Academy of Sciences.
The National Academy of Engineering was established in 1964, under the charter of the National Academy of Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. Wm.A.Wulf is president of the National Academy of Engineering.
The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appropriate professions in the examination of policy matters pertaining to the health of the public. The Institute acts under the responsibility given to the National Academy of Sciences by its congressional charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. Dr. Kenneth I.Shine is president of the Institute of Medicine.
The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad community of science and technology with the Academy’s purposes of furthering knowledge and advising the federal government. Functioning in accordance with general policies determined by the Academy, the Council has become the principal operating agency of both the National Academy of Sciences and the National Academy of Engineering in providing services to the government, the public, and the scientific and engineering communities. The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Bruce M.Alberts and Dr. Wm.A.Wulf are chairman and vice chairman, respectively, of the National Research Council.
OCR for page R4
Capitalizing on New Needs and New Opportunities: Government-Industry Partnerships in Biotechnology and Information Technologies
This page in the original is blank.
OCR for page R5
Capitalizing on New Needs and New Opportunities: Government-Industry Partnerships in Biotechnology and Information Technologies
Steering Committee for Government-Industry Partnerships for the Development of New Technologies *
Gordon Moore, Chair Chairman Emeritus, retired
Intel Corporation
M.Kathy Behrens Managing Partner
Robertson Stephens Investment Management and STEP Board
Michael Borrus Managing Director
The Petkevich Group, LLC
Iain M.Cockburn Professor of Finance and Economics
Boston University
Kenneth Flamm Dean Rusk Chair in International Affairs
LBJ School of Public Affairs University of Texas at Austin
James F.Gibbons Professor of Engineering
Stanford University
W.Clark McFadden Partner
Dewey Ballantine
Burton J.McMurtry General Partner
Technology Venture Investors
William J.Spencer, Vice-Chair Chairman Emeritus
International SEMATECH and STEP Board
Mark B.Myers Senior Vice-President, retired
Xerox Corporation and STEP Board
Richard Nelson George Blumenthal Professor of International and Public Affairs
Columbia University
Edward E.Penhoet Dean,
School of Public Health University of California at Berkeley and STEP Board
Charles Trimble Chairman
U.S. GPS Industry Council
John P.Walker Chairman and Chief Executive Officer
Axys Pharmaceuticals, Inc.
Patrick Windham President,
Windham Consulting and Lecturer, Stanford University
*
As of August 2001.
OCR for page R6
Capitalizing on New Needs and New Opportunities: Government-Industry Partnerships in Biotechnology and Information Technologies
Project Staff*
Charles W.Wessner Study Director
McAlister T.Clabaugh Program Associate
David E.Dierksheide Program Associate
Christopher S.Hayter Program Associate
Sujai J.Shivakumar Consultant
Contributors
Paula Stephan
Georgia State University
Grant Black
Georgia State University
Wesley M.Cohen
Carnegie Mellon University
Kenneth Flamm
University of Texas at Austin
Michael McGeary
McGeary and Smith
John Walsh
University of Illinois at Chicago
*
As of August 2001
OCR for page R7
Capitalizing on New Needs and New Opportunities: Government-Industry Partnerships in Biotechnology and Information Technologies
For the National Research Council (NRC), this project was overseen by the Board on Science, Technology and Economic Policy (STEP), a standing board of the NRC established by the National Academies of Sciences and Engineering and the Institute of Medicine in 1991. The mandate of the STEP Board is to integrate understanding of scientific, technological, and economic elements in the formulation of national policies to promote the economic well-being of the United States. A distinctive characteristic of STEP’s approach is its frequent interactions with public and private-sector decision makers. STEP bridges the disciplines of business management, engineering, economics, and the social sciences to bring diverse expertise to bear on pressing public policy questions. The members of the STEP Board* and the NRC staff are listed below:
Dale Jorgenson, Chair Frederic Eaton Abbe Professor of Economics
Harvard University
M.Kathy Behrens Managing Partner
Robertson Stephens Investment Management
Vinton G.Cerf Senior Vice-President
WorldCom
Bronwyn Hall Professor of Economics
University of California at Berkeley
James Heckman
Henry Schultz Distinguished Service
Professor of Economics
University of Chicago
Ralph Landau Consulting Professor of Economics
Stanford University
Richard Levin President
Yale University
William J.Spencer, Vice-Chair Chairman Emeritus
International SEMATECH
David T.Morgenthaler Founding Partner
Morgenthaler
Mark B.Myers Senior Vice-President, retired
Xerox Corporation
Roger Noll
Morris M. Doyle Centennial
Professor of Economics
Stanford University
Edward E.Penhoet Dean,
School of Public Health University of California at Berkeley
William Raduchel Chief Technology Officer
AOL Time Warner
Alan Wm.Wolff Managing Partner
Dewey Ballantine
*
As of August 2001.
OCR for page R8
Capitalizing on New Needs and New Opportunities: Government-Industry Partnerships in Biotechnology and Information Technologies
STEP Staff*
Stephen A.Merrill Executive Director
Philip Aspden Senior Program Officer
Craig M.Schultz Senior Program Officer
Camille M.Collett Program Associate
David E.Dierksheide Program Associate
Charles W.Wessner Program Director
Sujai J.Shivakumar Consultant
Adam Korobow Consultant
McAlister T.Clabaugh Program Associate
Christopher S.Hayter Program Associate
*
As of September 2001.
OCR for page R9
Capitalizing on New Needs and New Opportunities: Government-Industry Partnerships in Biotechnology and Information Technologies
National Research Council
Board on Science, Technology, and Economic Policy
Sponsors
The National Research Council gratefully acknowledges the support of the following sponsors:
National Aeronautics and Space Administration
Office of the Director, Defense Research & Engineering
National Science Foundation
U.S. Department of Energy
Office of Naval Research
National Institutes of Health
National Institute of Standards and Technology
Sandia National Laboratories
Electric Power Research Institute
International Business Machines
Kulicke and Soffa Industries
Merck and Company
Milliken Industries
Motorola
Nortel
Proctor and Gamble
Silicon Valley Group, Incorporated
Advanced Micro Devices
Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the project sponsors.
OCR for page R10
Capitalizing on New Needs and New Opportunities: Government-Industry Partnerships in Biotechnology and Information Technologies
This page in the original is blank.
OCR for page R11
Capitalizing on New Needs and New Opportunities: Government-Industry Partnerships in Biotechnology and Information Technologies
Contents
PREFACE
1
EXECUTIVE SUMMARY
14
I.
INTRODUCTION AND OVERVIEW
21
II.
ISSUES IN BIOTECHNOLOGY AND INFORMATION TECHNOLOGY
33
III.
FINDINGS AND RECOMMENDATIONS
51
IV.
PROCEEDINGS
71
Welcome
Dale Jorgenson, Harvard University
73
Introduction
Bill Spencer, SEMATECH
76
Opening Remarks
Congressman Sherwood Boehlert (R-NY)
78
Panel I: Biotechnology and Information Technologies: The Need for a Diversified Federal Research Portfolio
Moderator: Clark McFadden, Dewey Ballantine
84
OCR for page R12
Capitalizing on New Needs and New Opportunities: Government-Industry Partnerships in Biotechnology and Information Technologies
The View From the Semiconductor and Biotechnology Industries
Gordon Moore, Intel Corporation Edward Penhoet, University of California at Berkeley and Chiron Corporation
85
Discussion
95
Panel II: A Historical Perspective: Federal Partnerships in Computing and Biotechnology
Moderator: Patrick Windham, Stanford University
98
Partnerships in the Computer Industry
Kenneth Flamm, University of Texas at Austin
98
Partnerships in the Biotechnology Industry
Leon Rosenberg, Princeton University
111
Trends in Federal Research
William Bonvillian, Office of Senator Joseph Lieberman
116
Luncheon Address: “The Cornucopia of the Future”
Dan Goldin, NASA
120
Panel III: Biotechnology: Needs and Opportunities
Moderator: Edward Penhoet, University of California at Berkeley and Chiron Corporation
129
Exploiting the Biotechnology Revolution: Training and Tools
Marvin Cassman, National Institute of General Medical Sciences, NIH
129
The New Frontier: Bioinformatics and the University
Rita Colwell, National Science Foundation
135
Emerging Opportunities and Emerging Gaps
Paula Stephan, Georgia State University
139
Discussant:
Greg Reyes, Schering-Plough Stephen Dahms, San Diego State University
144
OCR for page R13
Capitalizing on New Needs and New Opportunities: Government-Industry Partnerships in Biotechnology and Information Technologies
Discussion
145
Panel IV: Information Technology: New Opportunities—New Needs
Moderator: Dave Goldston, Office of Congressman Boehlert
146
Biofutures for Multiple Missions
Jane Alexander, DARPA
146
Meeting the Needs: Realizing the Opportunities
Paul Horn, IBM
149
New Information Technology Research Initiatives
Tom Kalil, National Economic Council
152
Discussants:
Charles Trimble, Trimble Navigation Richard Rosenbloom, Harvard Business School
155
Discussion
157
Panel V:Capturing New Opportunities
Moderator: Michael Borrus, Pektevich & Partners, LLC
160
Computing and the Human Genome
Mark Boguski, National Center for Biotechnology Information
160
NanoFrontiers
Alton Romig, Sandia National Laboratories
165
Defense Interests and Applications
Timothy Coffey, Naval Research Laboratory
169
Discussion
171
Panel VI: Intellectual Property and the Public Domain: Sectoral Perspectives
Moderator: Jorge Goldstein, Stern, Kessler, Goldstein & Fox
173
Sectoral Variations in the Role of Intellectual Property
Wesley Cohen, Carnegie Mellon University
174
Post Bayh-Dole University-Industry Relationships
Maryann Feldman, Johns Hopkins University
179
OCR for page R14
Capitalizing on New Needs and New Opportunities: Government-Industry Partnerships in Biotechnology and Information Technologies
Intellectual Property and Biotechnology
Robert Blackburn, Chiron Corporation
183
Discussion
189
Concluding Remarks
Gordon Moore, Intel Corporation
191
V.
RESEARCH PAPERS
193
The Federal Partnership with U.S. Industry in U.S. Computer Research: History and Recent Concerns
Kenneth Flamm, University of Texas at Austin
195
Public Research, Patents, and Implications for Industrial R&D in the Drug, Biotechnology, Semiconductor and Computer Industries
Wesley M.Cohen, Carnegie Mellon University John Walsh, University of Illinois at Chicago
223
Bioinformatics: Emerging Opportunities and Emerging Gaps
Paula E.Stephan, Georgia State University Grant Black, Georgia State University
244
Recent Trends in the Federal Funding of Research and Development Related to Health and Information Technology
Michael McGeary, McGeary and Smith
261
VI.
ANNEX
319
A. Biographies of Contributors
321
B. Participants List
327
C. Bibliography
335